4.4 Article

Outcomes of the Supris Sling in an Urban Latina Population

Journal

UROLOGY
Volume 163, Issue -, Pages 3-7

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2021.07.054

Keywords

-

Funding

  1. Coloplast

Ask authors/readers for more resources

The Supris mid-urethral sling showed significant improvement in symptoms, especially for patients with pre-operative urge incontinence. Despite persistent urge symptoms, patients reported an overall improvement in their symptoms.
OBJECTIVE To analyze patient reported outcomes, safety, and efficacy of the Supris mid-urethral sling in a diverse population. METHODS A retrospective chart review of 101 women who underwent a mid-urethral Suprissling procedure was conducted. Baseline characteristics and perioperative parameters were collected. Post -operative results and patient reported outcomes were collected at an average follow-up time of 19 months using the Urogenital Distress Inventory-6 (UDI-6) and Patient Global Impression of Improvement (PGI-I) validated questionnaires. Subjective cure rates were compared using the nonparametric Wilcoxon Rank Sum Test. RESULTS The median age of women was 57 years old, and 86.1% identified as Latina. 28% and 72% of women had a SUI and MUI diagnosis, respectively. Women, on average, used 2 pads pre -operatively and none post-operatively. There was a 3% surgical revision rate. 80 women completed the questionnaires. 82% of the MUI group reported being very much improved or much better. The SUI group reported being 94% very much improved or much better. The UDI-6 questions related to urgency and leakage of small amounts of urine were significantly different between the MUI and SUI groups (P = .002 and P = .044). CONCLUSION In our primarily Latina patient population, the majority of whom had MUI, the Supris retropubic sling greatly improved symptoms. Although reported outcomes were excellent in both groups, those with pre-operative urge incontinence were more likely to experience urge symptoms postoperatively. Despite persistent urge symptoms, patients reported improvement of their overall symptoms. UROLOGY 163: 3-7, 2022. (c) 2021 Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available